cancer

Acrivon Therapeutics (ACRV) IPO deck Members Public

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.

Debarshi Ghosh
Healthcare

Syndax IPO reboot may help the fight against cancer tumors Members Public

Kris Tuttle
Healthcare

Aclaris Could be a Sleeper Members Public

Kris Tuttle
Healthcare